Do We Need Large-Scale Randomized Double Blind Clinical Trials for Medical Cannabis?

If you’ve been following current events on medical cannabis, you will have heard its critics claim there have been no clinical trials to demonstrate it usefulness.  The critics include, to name a few, the President of the Canadian Medical Association; the Canadian Minister of Health; the Director of the National Institute for Drug Abuse, the FDA and the National Institutes of Health in the US, and medical authorities in England and Wales.  The news media carry stories on the subject daily and, whilst some are sympathetic to patients seeking remedies, nearly all echo the above on the lack of scientific evidence, also called ‘hard evidence.’

Clinical trials are experiments conducted by researchers to answer a question about the usefulness of a proposed treatment.  The largest ones are conducted in 3 phases: phase I with 30-40 subjects; phase II with 80-100 subjects; and phase III with 1,000-3,000 subjects.  The treatment is...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://cannabisdigest.ca/do-we-need-large-scale-randomized-double-blind-clinical-trials-for-medical-cannabis/